Alamar Bio
formerly Alamar BiosciencesIPOAlamar Bio is a biotech company in Fremont, United States, founded in 2018. It has raised $258.3M across 6 rounds, most recently a $50.0M Convertible Note in January 2026.
Powering Precision Proteomics.
- Headquarters
- Fremont, California
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- alamarbio.com
- Total Funding
- $258.3M
- Last Round
- $50.0M Convertible NoteJan 2026
- Rounds
- 6
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 6 funding rounds and 10 investors for this company. The full record is or through the API.
About
Alamar Biosciences (also known as Alamar Bio) is a precision proteomics life sciences company headquartered in Fremont, California, founded in 2018. The company's mission is to power precision proteomics to enable the earliest detection of disease. Alamar's core innovation, the NULISA technology platform, enables ultra-high sensitivity and high specificity analysis of hundreds of protein biomarkers from as little as 10 microliters of biofluid in a single sample. Products include the ARGO HT System and a growing portfolio of NULISAseq and NULISAqpcr assay panels spanning immunology, neurology, and oncology indications. The company filed for an IPO on Nasdaq in early 2026 targeting a $100M raise, having achieved $74M in revenue with 195% year-over-year growth.
Summary
It lists 51–200 employees. It has raised $258.3M in total across 6 rounds, most recently a $50.0M Convertible Note round in Jan 2026. Investors include Illumina Ventures, Qiming VP and Sands Capital.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Apr 2026
Sign up to see all 7 events
Funding: Series A through Convertible Note. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alamar-bio"><img src="https://indexed.vc/api/badge/company/alamar-bio" alt="Alamar Bio on Indexed.vc" width="260" height="76" /></a>